Your browser doesn't support javascript.
loading
Low value of second-look endoscopy for detecting residual colorectal cancer after endoscopic removal.
Gijsbers, Kim M; Post, Zoë; Schrauwen, Ruud W M; Tang, Thjon J; Bisseling, Tanya M; Bac, Dirk J; Veenstra, Renzo P; Schreuder, Ramon-Michel; Epping Stippel, Ludger S M; de Vos Tot Nederveen Cappel, Wouter H; Slangen, Rob M E; van Lelyveld, Niels; Witteman, Ellen M; van Milligen de Wit, Marc A W M; Honkoop, Pieter; Alderlieste, Yasser; Ter Borg, Pieter J C; van Roermund, Rolf; Schmittgens, Stephan; Dekker, Evelien; Leeuwenburgh, Ivonne; de Ridder, Rogier J J; Zonneveld, Anke M; Hadithi, Muhammed; van Leerdam, Monique E; Bruno, Marco J; Vleggaar, Frank P; Moons, Leon M G; Koch, Arjun D; Ter Borg, Frank.
Afiliação
  • Gijsbers KM; Department of Gastroenterology and Hepatology, Deventer Ziekenhuis, Deventer, the Netherlands.
  • Post Z; Department of Gastroenterology and Hepatology, Deventer Ziekenhuis, Deventer, the Netherlands; Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
  • Schrauwen RWM; Department of Gastroenterology and Hepatology, Ziekenhuis Bernhoven, Uden, the Netherlands.
  • Tang TJ; Department of Gastroenterology and Hepatology, Ijsselland Ziekenhuis, Capelle aan de Ijssel, the Netherlands.
  • Bisseling TM; Department of Gastroenterology and Hepatology, RadboudUMC, Nijmegen, the Netherlands.
  • Bac DJ; Department of Gastroenterology and Hepatology, Ziekenhuis Gelderse Vallei, Ede, the Netherlands.
  • Veenstra RP; Department of Gastroenterology and Hepatology, Martini Ziekenhuis, Groningen, the Netherlands.
  • Schreuder RM; Department of Gastroenterology and Hepatology, Catharina Ziekenhuis, Eindhoven, the Netherlands.
  • Epping Stippel LSM; Department of Gastroenterology and Hepatology, Maasziekenhuis Pantein, Boxmeer, the Netherlands.
  • de Vos Tot Nederveen Cappel WH; Department of Gastroenterology and Hepatology, Isala Klinieken, Zwolle, the Netherlands.
  • Slangen RME; Department of Gastroenterology and Hepatology, HAGA Ziekenhuis, Den Haag, the Netherlands.
  • van Lelyveld N; Department of Gastroenterology and Hepatology, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands.
  • Witteman EM; Department of Gastroenterology and Hepatology, Canisius Wilhelmina Ziekenhuis, Nijmegen, the Netherlands.
  • van Milligen de Wit MAWM; Department of Gastroenterology and Hepatology, Amphia Ziekenhuis, Breda, the Netherlands.
  • Honkoop P; Department of Gastroenterology and Hepatology, Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands.
  • Alderlieste Y; Department of Gastroenterology and Hepatology, Rivas Zorggroep, Gorinchem, the Netherlands.
  • Ter Borg PJC; Department of Gastroenterology and Hepatology, Ikazia Ziekenhuis, Rotterdam, the Netherlands.
  • van Roermund R; Department of Gastroenterology and Hepatology, Ziekenhuis Groep Twente, Almelo, the Netherlands.
  • Schmittgens S; Department of Gastroenterology and Hepatology, Ziekenhuis Nij Smellinghe, Drachten, the Netherlands.
  • Dekker E; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, the Netherlands.
  • Leeuwenburgh I; Department of Gastroenterology and Hepatology, Franciscus, location Gasthuis and Vlietland, Rotterdam, the Netherlands.
  • de Ridder RJJ; Department of Gastroenterology and Hepatology, Maastricht UMC+, Maastricht, the Netherlands.
  • Zonneveld AM; Department of Gastroenterology and Hepatology, Ziekenhuis Nij Smellinghe, Drachten, the Netherlands; Department of Gastroenterology and Hepatology, Antonius Ziekenhuis Sneek-Emmeloord, Sneek, the Netherlands.
  • Hadithi M; Department of Gastroenterology and Hepatology, Maasstad Ziekenhuis, Rotterdam, the Netherlands.
  • van Leerdam ME; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Bruno MJ; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
  • Vleggaar FP; Department of Gastroenterology and Hepatology, Utrecht Medical University Center, Utrecht, the Netherlands.
  • Moons LMG; Department of Gastroenterology and Hepatology, Utrecht Medical University Center, Utrecht, the Netherlands.
  • Koch AD; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
  • Ter Borg F; Department of Gastroenterology and Hepatology, Deventer Ziekenhuis, Deventer, the Netherlands.
Gastrointest Endosc ; 92(1): 166-172, 2020 07.
Article em En | MEDLINE | ID: mdl-32105713
BACKGROUND AND AIMS: Endoscopic resection is often feasible for submucosal invasive colorectal cancers (T1 CRCs) and usually judged as complete. If histology casts doubt on the radicality of resection margins, adjuvant surgical resection is advised, although residual intramural cancer is found in only 5% to 15% of patients. We assessed the sensitivity of biopsy specimens from the resection area for residual intramural cancer as a potential tool to estimate the preoperative risk of residual intramural cancer in patients without risk factors for lymph node metastasis (LNM). METHODS: In this multicenter prospective cohort study, patients with complete endoscopic resection of T1 CRC, scheduled for adjuvant resection due to pathologically unclear resection margins, but absent risk factors for LNM, were asked to consent to second-look endoscopy with biopsies. The results were compared with the pathology results of the surgical resection specimen (criterion standard). RESULTS: One hundred three patients were included. In total, 85% of resected lesions were unexpectedly malignant, and 45% were removed using a piecemeal resection technique. Sixty-four adjuvant surgical resections and 39 local full-thickness resections were performed. Residual intramural cancer was found in 7 patients (6.8%). Two of these patients had cancer in second-look biopsy specimens, resulting in a sensitivity of 28% (95% confidence interval, <58%). The preoperative risk of residual intramural cancer in the case of negative biopsy specimens was not significantly reduced (P = .61). CONCLUSIONS: The sensitivity of second-look endoscopy with biopsies for residual intramural cancer after endoscopic resection of CRC is low. Therefore, it should not be used in the decision whether or not to perform adjuvant resection. (Clinical trial registration number: NCT02328664.).
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article